Transcriptional regulation of human survivin by early growth response (Egr)-1 transcription factor

Mandy Wagner1, Karin Schmelz, Bernd Dörken

  • 1Department of Hematology and Oncology, Universitätsmedizin Berlin, Charité, Campus Virchow, Augustenburger Platz 1, 13353 Berlin, Germany.

Insights

This study identifies a new way to control survivin, a protein linked to cancer cell division and survival. The early growth response 1 (Egr-1) transcription factor can reduce survivin levels, potentially making cancer cells more vulnerable to apoptosis.

Area of Science:

  • Molecular Biology
  • Cancer Research
  • Cell Biology

Background:

  • Survivin, an inhibitor of apoptosis protein, is crucial for cell division and survival.
  • Its tumor-specific expression makes survivin a promising therapeutic target for malignant diseases.
  • Understanding survivin's transcriptional regulation is key for developing new anti-cancer strategies.

Purpose of the Study:

  • To investigate the transcriptional regulation of survivin.
  • To identify novel regulatory regions within the survivin promoter.
  • To establish survivin as a target gene for novel therapeutic approaches.

Main Methods:

  • Analysis of the human survivin promoter region.
  • Treatment with phorbol 12-myristate-13-acetate to induce Egr-1.
  • In vitro and in cellulo binding assays for Egr-1 to the survivin promoter.
  • Reporter-gene assays and overexpression experiments.
  • Utilizing p53 wildtype and mutated cell lines.

Main Results:

  • A novel regulatory region in the survivin promoter was identified.
  • The early growth response 1 (Egr-1) transcription factor binds to a specific sequence (5'GAGGGGGCG 3') in the survivin promoter.
  • Exogenous expression of wildtype Egr-1 downregulates survivin expression.
  • Egr-1 negatively regulates survivin expression and sensitizes cells to TRAIL-induced apoptosis, particularly in p53 wildtype cells.

Conclusions:

  • Egr-1 acts as a negative regulator of survivin expression.
  • The Egr-1/survivin pathway offers a potential new therapeutic strategy for cancer treatment.
  • Targeting Egr-1 could enhance apoptosis in tumor cells, leading to improved treatment outcomes.

Related Concept Videos

Master Transcription Regulators02:23

Master Transcription Regulators

Master transcription regulators are regulatory proteins that are predominantly responsible for regulating the expression of multiple genes. Often these genes work in concert to drive a  complex process. Activation of a master transcription regulator can lead to a cascade of transcriptional activation necessary for that outcome. These regulators can directly bind to the regulatory sequences of the various genes involved, or they can indirectly regulate transcription by binding to regulatory...
Master Transcription Regulators02:23

Master Transcription Regulators

Master transcription regulators are regulatory proteins that are predominantly responsible for regulating the expression of multiple genes. Often these genes work in concert to drive a  complex process. Activation of a master transcription regulator can lead to a cascade of transcriptional activation necessary for that outcome. These regulators can directly bind to the regulatory sequences of the various genes involved, or they can indirectly regulate transcription by binding to regulatory...
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...
General Transcription Factors01:30

General Transcription Factors

Tissue-specific transcription factors contribute to diverse cellular functions in mammals. For example, the gene for beta globin, a major component of hemoglobin, is present in all cells of the body. However, it is only expressed in red blood cells because the transcription factors that can bind to the promoter sequences of the beta globin gene are only expressed in these cells. Tissue-specific transcription factors also ensure that mutations in these factors may impair only the function of...
Transcription01:10

Transcription

Overview
Transcription is the process of synthesizing RNA from a DNA sequence by RNA polymerase. It is the first step in producing a protein from a gene sequence. Additionally, many other proteins and regulatory sequences are involved in the proper synthesis of messenger RNA (mRNA). Regulation of transcription is responsible for the differentiation of all the different types of cells and often for the proper cellular response to environmental signals.
Transcription Can Produce Different Kinds...
Transcription01:17

Transcription

Transcription is the synthesis of RNA from a DNA sequence by RNA polymerase. It is the first step in producing a protein from a gene sequence. Additionally, many other proteins and regulatory sequences are involved in correctly synthesizing messenger RNA (mRNA). Transcriptional regulation is responsible for the differentiation of different types of cells and often for the proper cellular response to environmental signals.
Transcription Can Produce Different Kinds of RNA Molecules
In eukaryotes,...